Adlai Nortye Group Ltd. (ANL)
NASDAQ: ANL · Real-Time Price · USD
15.22
-0.30 (-1.93%)
At close: Sep 17, 2026, 4:00 PM EDT
15.28
+0.06 (0.39%)
After-hours: Sep 17, 2026, 4:50 PM EDT
Adlai Nortye Group Market Cap
Adlai Nortye Group has a market cap or net worth of $980.14 million as of September 17, 2026. Its market cap has increased by 1,383.90% in one year.
Market Cap
980.14M
Enterprise Value
774.02M
1-Year Change
1,383.90%
Ranking
Category
Stock Price
$15.22
ChartMarket Cap Chart
Since the IPO on September 29, 2023, Adlai Nortye Group's market cap has increased from $553.50M to $980.14M, an increase of 77.08%. That is a compound annual growth rate of 21.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 980.14M | 1,770.55% |
| Dec 31, 2025 | 52.40M | -47.12% |
| Dec 31, 2024 | 99.08M | -70.13% |
| Dec 29, 2023 | 331.73M | -40.07% |
| Sep 29, 2023 | 553.50M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Obsidian Therapeutics | 1.12B |
| Corvus Pharmaceuticals | 1.10B |
| MoonLake Immunotherapeutics | 1.08B |
| Apnimed | 1.06B |
| Janux Therapeutics | 1.06B |
| Kura Oncology | 1.03B |
| Arbutus Biopharma | 1.01B |
| Faeth Therapeutics | 1.01B |